Compass Therapeutics Inc. (CMPX)
Healthcare
Biotechnology
1.90 $
-1.3%
vs. previous close
Closing price · As of: 3. Aug 2026
Compass Therapeutics Inc. (CMPX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -49 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| -34 | -32 | -27 | -20 | -34 | -41 | -45 | -49 | |
| 1.9 | 2.1 | 2.4 | 1.6 | 1.9 | 1.9 | 1.8 | -1.4 | |
| 0.7 | 0.9 | 4.0 | 4.0 | 5.3 | 6.1 | 8.6 | 8.4 | |
| 0.5 | 1.1 | 4.9 | 55 | 5.3 | – | – | – | |
| 2.2 | -0.3 | -3.6 | 6.2 | -1.3 | -2.9 | -4.1 | 9.2 | |
| 2.0 | 0.5 | 0.1 | 1.6 | 0.2 | 0.0 | 0.0 | 0.0 | |
| -2.0 | -0.5 | 0.0 | -1.8 | -151 | 27 | 47 | -93 | |
| – | – | 54 | 128 | 76 | 0.0 | – | – | |
| 15 | -5.6 | -5.6 | -9.4 | 0.0 | – | – | – | |
| 64 | 0.0 | 49 | 119 | 76 | 2.9 | 17 | 130 | |
| 28 | -32 | 22 | 97 | -110 | -11 | 19 | -13 | |
| -36 | -32 | -27 | -21 | -34 | -41 | -45 | -49 |
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.